Colson Medical Announces Hjalmar Pompe van Meerdervoort as New Acumed President

June 1, 2022

Colson Medical, LLC announces Hjalmar Pompe van Meerdervoort as President, Acumed, effective June 1. Pompe van Meerdervoort succeeds Sharon Wolfngton, who will transition into a new advisory role for Colson Medical, LLC. After nearly five years at Acumed, Wolfington chose to pursue other professional and personal opportunities.

Pompe van Meerdervoort brings extensive global healthcare experience with his more than 25-year career in orthopaedics and medical devices. Most recently, he was Senior Vice President and General Manager, Reconstruction at Smith+Nephew where he led the commercial functions for Smith+Nephew’s reconstructive joint portfolio.

Prior to Smith+Nephew, Pompe van Meerdervoort served as cofounder and CEO of VisionScope Technologies, an office-based arthroscopic imaging company. He was also Vice President and General Manager, Knees, at Zimmer Holdings, where he managed the company’s $2 billion flagship segment. He spent more than 10 years of his early career at Stryker Corporation growing his responsibility and reach to include international assignments. Throughout his career, Pompe van Meerdervoort has been driven by a passion to help heal the afficted and lead teams to deliver solutions that optimize patient outcomes and streamline care delivery.

“Over the past few months, we have conducted an extensive search to select the next leader of Acumed” said Chris J. Smith, President, Colson Medical, LLC. “With his exceptional track record of leading teams and businesses to achieve superior results, we believe Hjalmar is the ideal President to lead Acumed in its next chapter of growth and success.”

Wolfington will transition into a new advisory role at Colson Medical, LLC focused on key areas including thought leader management, business development, and clinical research strategy. “We thank Sharon for her many contributions to Acumed. She has provided leadership to establish a robust innovation pipeline and deliver excellence to our customers through education, evidence, innovation, and quality,” said Smith. “We are pleased Sharon will continue with Colson Medical in service to the global medical community.”